WST Financial Facts
Selling, general and administrative expenses: 58.3MGross profit: 121.1M
See Full Income Statement
Total Liabilities: 593M
Inventories: 201.1M
See Full Balance Sheet
West Pharmaceutical Services, Inc. (WST) Earnings
|
Expand Research on WST
| Next EPS Date | 7/24/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +16.6% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/26  |
Q126 | N/A | $1.68 | N/A | N/A | $777.68M | = | N/A | N/A | ||
| 2/12/26 | Q425 | $2.04 | $1.84 | +$0.20 | $805M | $796.25M | = |  | | Details | |
| 10/23/25 | Q325 | $1.96 | $1.69 | +$0.27 | $804.6M | $786.33M | = | | | Details | |
| 7/24/25 | Q225 | $1.84 | $1.51 | +$0.33 | $766.5M | $725.26M | = | | | Details | |
| 4/24/25 | Q125 | $1.45 | $1.23 | +$0.22 | $698M | $684.94M | = | | | Details | |
| 2/13/25 | Q424 | $1.82 | $1.72 | +$0.10 | $748.8M | $740.75M | = | | | Details | |
| 10/24/24 | Q324 | $1.85 | $1.50 | +$0.35 | $746.9M | $709.3M | = | | | Details | |
| 7/25/24 | Q224 | $1.52 | $1.74 | -$0.22 | $702.1M | $729.36M | = | | | Details |
